Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 2 (2006), Issue 5 (May)

1. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.
   J Clin Oncol, 24(13): 2098-104. [Abstract] [Full-text]
2. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13.
   J Clin Oncol, 24(13): 2092-7. [Abstract] [Full-text]
3. Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology.
   Mol Imaging Biol, 8(3): 141-50. [Abstract] [Full-text]
4. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
   Cancer, 106(10): 2208-17. [Abstract] [Full-text]
5. A systems approach to clinical oncology: focus on breast cancer.
   Proteome Sci, 4: 5. [Abstract] [Full-text]
6. Complementary and alternative medicine: oncology nurses' experiences, educational interests, and resources.
   Oncol Nurs Forum, 33(3): 581-8. [Abstract] [Full-text]
7. Legal and ethical issues relating to use of complementary therapies in pediatric hematology/oncology.
   J Pediatr Hematol Oncol, 28(3): 190-3. [Abstract] [Full-text]
8. Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group pilot feasibility study.
   J Pediatr Hematol Oncol, 28(4): 210-5. [Abstract] [Full-text]
9. Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.
   Invest New Drugs, 24(4): 335-41. [Abstract] [Full-text]
10. The Wnt-dependent signaling pathways as target in oncology drug discovery.
    Invest New Drugs, 24(4): 263-80. [Abstract] [Full-text]
11. The impact of obesity on surgery in gynecological oncology: a review.
    Int J Gynecol Cancer, 16(2): 944-52. [Abstract] [Full-text]
12. Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group.
    Int J Gynecol Cancer, 16(2): 660-3. [Abstract] [Full-text]
13. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia.
    Eur J Cancer, 42(7): 909-16. [Abstract] [Full-text]
14. Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial.
    Invest New Drugs, 24(2): 151-8. [Abstract] [Full-text]
15. Mindfulness meditation for oncology patients: a discussion and critical review.
    Integr Cancer Ther, 5(2): 98-108. [Abstract] [Full-text]
16. Resident training in neurosurgical oncology: results of the survey of North American training programs by the AANS/CNS Section on Tumors.
    J Neurooncol, 77(3): 241-6. [Abstract] [Full-text]
17. A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.
    J Neurooncol, 77(2): 193-8. [Abstract] [Full-text]
18. Satisfaction with care: an independent outcome measure in surgical oncology.
    Ann Surg Oncol, 13(6): 817-22. [Abstract] [Full-text]
19. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
    Gynecol Oncol, 101(2): 296-304. [Abstract] [Full-text]
20. Discrepancy of death diagnosis in gynecology oncology.
    Gynecol Oncol, 101(2): 311-4. [Abstract] [Full-text]
21. Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ann Hematol, 85(7): 424-33. [Abstract] [Full-text]
22. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
    J Clin Oncol, 24(15): 2332-6. [Abstract] [Full-text]
23. Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit.
    J Clin Oncol, 24(15): 2298-303. [Abstract] [Full-text]
24. Norovirus outbreak in a pediatric oncology unit.
    Scand J Gastroenterol, 41(6): 693-9. [Abstract] [Full-text]
25. Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology.
    Eur J Radiol, 58(3): 383-9. [Abstract] [Full-text]
26. Use of genomic signatures in therapeutics development in oncology and other diseases.
    Pharmacogenomics J, 6(3): 166-73. [Abstract] [Full-text]
27. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group.
    Cancer Chemother Pharmacol, 58(3): 343-7. [Abstract] [Full-text]
28. A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial.
    Cancer Chemother Pharmacol, 58(3): 368-73. [Abstract] [Full-text]
29. Why "radiation oncology".
    Radiat Oncol, 1: 1. [Abstract] [Full-text]
30. Sexual rehabilitation medicine in a female oncology setting.
    Gynecol Oncol, 101(3): 380-4. [Abstract] [Full-text]
31. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.
    Gynecol Oncol, 101(3): 390-7. [Abstract] [Full-text]
32. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.
    Gynecol Oncol, 101(3): 429-35. [Abstract] [Full-text]
33. Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study.
    Gynecol Oncol, 101(3): 436-40. [Abstract] [Full-text]
34. Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up.
    Gynecol Oncol, 101(3): 423-8. [Abstract] [Full-text]
35. Radiation oncology emergencies.
    Hematol Oncol Clin North Am, 20(2): 505-22. [Abstract] [Full-text]
36. Sarcoma and skin radiation oncology.
    Hematol Oncol Clin North Am, 20(2): 401-29. [Abstract] [Full-text]
37. Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology.
    Eur J Surg Oncol, 32(5): 507-10. [Abstract] [Full-text]
38. Where does hematology end and oncology begin? Questions of professional boundaries and medical authority.
    J Clin Oncol, 24(16): 2583-8. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.